Company: FVN
Filing Date: 2025-01-07
Form Type: DRS/A
Source: 0001829126-25-000092
Chunk: 86

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-01-07
Form: DRS/A
Chunk 86
---
 at all. New products and services may not be profitable, and even if they are profitable, operating margins for some new products, services and businesses may not be as high as the margins VIWO has experienced historically. Furthermore, developing new technologies is complex and unpredictable, which can require long development and testing periods. Significant delays in new releases or significant problems in creating new products or offering new services could adversely affect VIWO’s revenue and profits.

<div align='center'>49</div>

VIWO requires a significant amount of capital to fund its research and development investments. If VIWO cannot obtain sufficient capital on favorable terms or at all, its business, financial condition and prospects may be materially and adversely affected.

Operating VIWO, its subsidiaries’ business requires significant, continuous investment in acquiring, maintaining and upgrading contents, services and technologies. Historically, VIWO has financed its operations primarily with net cash generated from operating activities, financial support from shareholders and equity financings and loans from third-parties. As part of VIWO’s growth strategy, VIWO plans to continue investing substantial capital in research and development activities in the future, which may require VIWO to obtain additional equity or debt financing. VIWO’s ability to obtain additional financing in the future is subject to a number of uncertainties, including but not limited to those relating to:

| ● | VIWO’s future business development, financial condition and results of operations; |
| ● | general market conditions for financing activities; and                            |
| ● | macro-economic and other conditions in China and elsewhere.                        |

Although VIWO expects to rely on net cash provided by operating activities and financing through capital markets for liquidity needs as VIWO’s business continues to grow and after it becomes a public company, there can be no assurances that VIWO will be successful in its efforts to diversify sources of liquidity. If VIWO raises additional funds through future issuances of equity or convertible debt securities, VIWO’s existing shareholders could suffer significant dilution, and any new equity securities VIWO issues could have rights, preferences and privileges superior to those of holders of VIWO’s ordinary shares. Any debt financing that VIWO secures in the future could involve restrictive covenants relating to VIWO’s capital raising activities and other financial and operational matters, including the ability to pay dividends. This may make it more difficult for VIWO to obtain additional capital to fund its research and development, and pursue business opportunities, including potential acquisitions. If VIWO is unable to obtain sufficient capital to meet capital needs, then it may not be